The UK’s infant vaccination programme against group B meningococcal disease has resulted in a significant reduction in cases of the disease in young children, according to research from Public Health England published in the New England Journal of Medicine.1
However, an Australian study published in the same journal found that while the meningitis B vaccine also works in teenagers it does not provide herd protection against the meningococcal bacteria so will only protect those who are adequately immunised.2
In September 2015 the UK became the first country to offer the 4CMenB vaccine (Bexsero) to babies at 8 and 16 weeks of age, followed by a booster at 12 months.
The results show that from September 2015 through to August 2018 there …

中文翻译：

---

脑膜炎疫苗：在英国属于病例，但在澳大利亚，牛群免疫仍然难以捉摸。

英国公共卫生署在《新英格兰医学杂志》上发表的研究表明，英国针对B组脑膜炎球菌疾病的婴儿疫苗接种计划已导致幼儿疾病病例显着减少。[1]
然而，同一刊物上发表的一项澳大利亚研究发现，尽管乙型脑膜炎疫苗也可以在青少年中发挥作用，但它并未提供针对脑膜炎球菌的畜群保护，因此只能保护那些进行了充分免疫的人。2
2015年9月，英国成为第一个向8周和16周龄的婴儿提供4CMenB疫苗（Bexsero）的国家，随后是12个月的增强型疫苗。
结果显示，从2015年9月到2018年8月